Genetic deletion or pharmacological inhibition of RAC1 in NRAS Q61K-induced melanoma has been shown to suppresses tumor growth, lymph node spread, and tumor cell invasiveness, suggesting a potential value for RAC1 inhibition in this type of tumors [94]. The gene discussed is RAC1; the disease is melanoma.